bosentan anhydrous has been researched along with Chagas Disease in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barcelos, LS; Camargos, ER; Chiari, E; Machado, CR; Rachid, MA; Tanowitz, HB; Teixeira, AL; Teixeira, MM | 1 |
Barcellos, L; Camargos, ER; Chiari, E; Huang, H; Machado, CR; Marques, CA; Rachid, MA; Tanowitz, HB; Teixeira, MM | 1 |
2 other study(ies) available for bosentan anhydrous and Chagas Disease
Article | Year |
---|---|
Role of endothelin receptors in the control of central nervous system parasitism in Trypanosoma cruzi infection in rats.
Topics: Animals; Antihypertensive Agents; Antiparasitic Agents; Bosentan; Brain; Chagas Disease; Cytokines; Disease Models, Animal; Encephalitis; Endothelin Receptor Antagonists; Endothelins; Immunity, Innate; Male; Rats; Rats, Sprague-Dawley; Receptors, Endothelin; Sulfonamides; Treatment Outcome; Trypanosoma cruzi; Up-Regulation | 2010 |
Blockade of endothelin ET(A)/ET(B) receptors favors a role for endothelin during acute Trypanosoma cruzi infection in rats.
Topics: Animal Structures; Animals; Bosentan; Chagas Disease; Chemokines; Cytokines; Diaphragm; Disease Models, Animal; Endothelin Receptor Antagonists; Endothelins; Male; Myocardium; Nitrates; Nitrites; Parasitemia; Rats; Sulfonamides; Trypanosoma cruzi | 2006 |